Table 3

Schedule of procedures

ScreeningBaseline (Pre-Tx)At TxDay 1 Post-TxDay 2 Post-TxDay 3 Post-TxDay 7 Post-TxMonth 3 Post-TxHospital discharge
Enrolment
Qualitative substudy—give Q1X
Eligibility assessmentX
Informed consentX
Baseline characteristicsX
Reconfirm consent/assentX
RandomisationX
Qualitative substudy—give Q2X
Treatment
Administration of trial fluidXXXX
Assessments
Transplant operation dataX
Blood results†XAll results for 72 hours from transplant ‘knife-to-skin’
Blood gas results†XAll results for 72 hours from transplant knife-to-skin
Patient weightXAll weights for 72 hours from transplant knife-to-skin
Fluid dataAll fluid for 72 hours from transplant knife-to-skin
Medication dataAll meds* for 72 hours from transplant ‘knife-to-skin’
Symptom assessmentXXX
DialysisXXX
Blood pressureXXXX
Safety reportingXXXX
Transplant graft functionXX‡
Discharge dateX
  • No additional tests are required for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children trial participants. This table summarises the data required at each timepoint.

  • *Data must be collected on all inotropes, diuretics, immunosuppressives, insulin, antiemetics and electrolyte supplements administered during this 72-hour period.

  • †Blood results and Venus blood gas data will be obtained directly from the Trust Pathology System (where possible), anonymised and then transferred to the Digital Research Environment at Great Ormond Street Hospital.

  • ‡Data will be obtained directly from the UK Transplant Registry, held by NHS Blood and Transplant (eg, patient ethnicity, blood group, donor details, matching details and transplant graft function).